Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging

NCT02400840 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study is not feasable yet, due to evolution in the patients' care

Conditions

Cardiac Graft

Interventions

PROCEDURE: cardiac MRI
DRUG: gadobenic acid intravenous injection 0.2 ml/kg

Sponsor

University Hospital, Rouen